Acrivon Therapeutics, Inc. (ACRV) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $129.72M | -34.0% |
| 2024 | $196.59M | +42.2% |
| 2023 | $138.26M | -23.7% |
| 2022 | $181.23M | +70.0% |
| 2021 | $106.59M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $129.72M | -34.0% |
| 2024 | $196.59M | +42.2% |
| 2023 | $138.26M | -23.7% |
| 2022 | $181.23M | +70.0% |
| 2021 | $106.59M | — |